Inventor
MACBETH KYLE J
US17 patents
⚠️ This page may combine multiple inventors who share the name “MACBETH KYLE J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MILLENNIUM PHARM INC
10 patentsUS6872811B1Mar 29, 2005
HRPCa9 and HRPCa10 nucleic acids and polypeptides
MILLENNIUM PHARM INC21 citations92
US7301016B2Nov 27, 2007
Human transferase family members and uses thereof
MILLENNIUM PHARM INC14 citations91
US6300092B1Oct 9, 2001
Methods of use of a novel lysyl oxidase-related protein
MILLENNIUM PHARM INC39 citations90
US5932422AAug 3, 1999
Modulation of drug resistance via ubiquitin carboxy-terminal hydrolase
MILLENNIUM PHARM INC10 citations73
US7485308B2Feb 3, 2009
26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor
MILLENNIUM PHARM INC5 citations62
US7071004B1Jul 4, 2006
14094, a novel human trypsin family member and uses thereof
MILLENNIUM PHARM INC2 citations62
US7098015B2Aug 29, 2006
27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
MILLENNIUM PHARM INC2 citations61
US6383780B1May 7, 2002
2786, a novel human aminopeptidase
MILLENNIUM PHARM INC1 citations52
US6369210B1Apr 9, 2002
22012, human carboxypeptidase
MILLENNIUM PHARM INC0 citations52
US6322982B1Nov 27, 2001
Modulation of drug resistance via ubiquitin carboxy-terminal hydrolase
MILLENNIUM PHARM INC0 citations51
CELGENE CORP
4 patentsUS8841277B2Sep 23, 2014
Methods for treating non-small cell lung cancer using 5-azacytidine
CELGENE CORP5 citations81
US9125884B2Sep 8, 2015
Methods for treating cancers using oral formulations of cytidine analogs
CELGENE CORP3 citations60
US9693987B2Jul 4, 2017
Methods for treating cancers using oral formulations of cytidine analogs
CELGENE CORP1 citations49
US9101579B2Aug 11, 2015
Inhibition of drug resistant cancer cells
CELGENE CORP0 citations49